Ole Hansen

910 total citations
17 papers, 705 citations indexed

About

Ole Hansen is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Ole Hansen has authored 17 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Reproductive Medicine and 4 papers in Surgery. Recurrent topics in Ole Hansen's work include Ovarian cancer diagnosis and treatment (8 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Ole Hansen is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Intraperitoneal and Appendiceal Malignancies (4 papers) and Cancer Treatment and Pharmacology (3 papers). Ole Hansen collaborates with scholars based in Denmark, Netherlands and United Kingdom. Ole Hansen's co-authors include Birthe Lund, Karen Theilade, Mads Hansen, J.P. Neijt, Lars Ovesen, Erik Lykke Mortensen, Jens Hannibal, Heine H. Hansen, M Hansen and Mogens Hansen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ole Hansen

17 papers receiving 684 citations

Peers

Ole Hansen
Vivian von Gruenigen United States
Giuseppe Scaletta Italy
Joerg Kotzerke Germany
Vincent Dochez France
Àngels Arcusa Spain
Naoko Sasamoto United States
B Kabakow United States
Ove Björ Sweden
Joëlle Blumberg France
Toshiyuki Sado Japan
Vivian von Gruenigen United States
Ole Hansen
Citations per year, relative to Ole Hansen Ole Hansen (= 1×) peers Vivian von Gruenigen

Countries citing papers authored by Ole Hansen

Since Specialization
Citations

This map shows the geographic impact of Ole Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Hansen more than expected).

Fields of papers citing papers by Ole Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Hansen. The network helps show where Ole Hansen may publish in the future.

Co-authorship network of co-authors of Ole Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Hansen. A scholar is included among the top collaborators of Ole Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Hansen. Ole Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tuxen, Malgorzata, Birthe Lund, Ole Hansen, K. Bertelsen, & Mads Hansen. (1997). Oral etoposide in elderly previously untreated ovarian cancer patients with residual disease. International Journal of Gynecological Cancer. 7(3). 213–217. 3 indexed citations
2.
Strauss, Gitte, Birthe Lund, M Hansen, Ole Hansen, & Heine H. Hansen. (1996). Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual disease. International Journal of Gynecological Cancer. 6(5). 410–414. 4 indexed citations
3.
Strauss, Gitte, Birthe Lund, M Hansen, Ole Hansen, & Heine H. Hansen. (1996). Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual disease. International Journal of Gynecological Cancer. 6(5). 410–410. 2 indexed citations
4.
Lund, Birthe, et al.. (1995). Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients. Anti-Cancer Drugs. 6(Supplement 6). 61–62. 42 indexed citations
5.
6.
Lund, Birthe, Ole Hansen, Karen Theilade, Mads Hansen, & J.P. Neijt. (1994). Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients. JNCI Journal of the National Cancer Institute. 86(20). 1530–1533. 296 indexed citations
7.
Oturai, Peter, Niels Henrik Holländer, Ole Hansen, et al.. (1993). Ceftriaxone versus latamoxef in febrile neutropenic patients: Empirical monotherapy in patients with solid tumours. European Journal of Cancer. 29(9). 1274–1279. 6 indexed citations
8.
9.
Tuxen, Malgorzata, Bente Lund, Ole Hansen, & M Hansen. (1993). Second-look laparotomy in the management of patients after radical surgery for ovarian cancer. Annals of Oncology. 4(2). 169–171. 3 indexed citations
10.
Nielsen, Dorte, et al.. (1992). Original article: Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy. Annals of Oncology. 3(5). 377–378. 7 indexed citations
11.
Lund, Birthe, Ole Hansen, Heine H. Hansen, & Mogens Hansen. (1992). Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.. PubMed. 19(1 Suppl 1). 26–9. 10 indexed citations
12.
Lund, Birthe, M Hansen, Ole Hansen, & Heine H. Hansen. (1990). Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.. Journal of Clinical Oncology. 8(7). 1226–1230. 33 indexed citations
13.
Lund, Birthe, M Hansen, Ole Hansen, & Heine H. Hansen. (1989). High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.. Journal of Clinical Oncology. 7(10). 1469–1473. 61 indexed citations
14.
Hermann, Gregers G., et al.. (1984). Primary hemangiosarcoma of the spleen with angioscintigraphic demonstration of metastases. Cancer. 53(8). 1682–1685. 15 indexed citations
15.
Hansen, Ole. (1984). Simultaneous quantification of red cell and platelet surface-bound IgG & IgM by an ELISA technique. Scandinavian Journal of Clinical and Laboratory Investigation. 44(sup168). 45–55. 6 indexed citations
16.
Hansen, Ole. (1981). Heavy-ion collisions, vol. 1. Nuclear Physics A. 351(3). 532–532. 12 indexed citations
17.
Hansen, Ole & Erik Hippe. (1974). [Pernicious anemia. Patients with misleading Schilling and absence of macrocytic anemia].. PubMed. 136(51). 2859–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivian von Gruenigen Breakdown of academic impact, for papers by Giuseppe Scaletta Breakdown of academic impact, for papers by Joerg Kotzerke Breakdown of academic impact, for papers by Vincent Dochez Breakdown of academic impact, for papers by Àngels Arcusa Breakdown of academic impact, for papers by Naoko Sasamoto Breakdown of academic impact, for papers by B Kabakow Breakdown of academic impact, for papers by Ove Björ Breakdown of academic impact, for papers by Joëlle Blumberg Breakdown of academic impact, for papers by Toshiyuki Sado
Rankless by CCL
2026